drugset / Trial / NCT00190879

Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder

NCT00190879

Phase 4 Completed 440 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the effect of atomoxetine hydrochloride in treating adults who have attention deficit hyperactivity disorder with comorbid social anxiety disorder

Timeline

Start
2005-06
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified